Unknown

Dataset Information

0

Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment.


ABSTRACT:

Background

Inflammatory bowel disease (IBD) and food-responsive diarrhea (FRD) are common chronic enteropathies in dogs, of which the exact pathogenesis has not been fully understood. In people dyslipidemia has been reported in patients with IBD, and potential therapeutic benefits of polyunsaturated fatty acids (PUFA) in the treatment of IBD have been investigated. Studies on the phospholipid profile in dogs with IBD and FRD are still lacking.

Aim

To investigate the systemic phospholipid profile of dogs with IBD or FRD and to evaluate possible differences in phospholipids before and after treatment.

Methods

The phospholipids in whole blood and EDTA plasma of 32 dogs diagnosed with either IBD (n = 16) or FRD (n = 16) were analyzed by hydrophilic interaction liquid chromatography (HILIC) prior to and after initiation of treatment, which included an elimination diet enriched with PUFAs.

Results

A clear separation of the phospholipids between whole blood and plasma was demonstrated on principal component analysis plots. In addition to the type of specimen, treatment and disease severity were the most significant factors determining the variance of the phospholipid profile. An increase in lysolipids was observed after treatment. The phosphatidylcholine (PC) species changed from PC 38:4 before treatment to mainly lysophosphatidylcholine 18:0 after treatment. Furthermore, several differences in the abundance of individual phospholipids were identified between dogs with IBD and dogs with FRD and between treatment statuses using random forest analysis.

Conclusion

Significant variances were identified in the phospholipid profiles of dogs with IBD and FRD. These were particularly determined by type of specimen used, disease severity and treatment status. After treatment, a shift of phospholipid species towards lysophosphatidylcholine 18:0 was observed. Future studies should further investigate the role of lipids in the pathophysiology of IBD and FRD as well as their potential therapeutic benefits.

SUBMITTER: Kalenyak K 

PROVIDER: S-EPMC6467395 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment.

Kalenyak Katja K   Heilmann Romy M RM   van de Lest Chris H A CHA   Brouwers Jos F JF   Burgener Iwan A IA  

PloS one 20190416 4


<h4>Background</h4>Inflammatory bowel disease (IBD) and food-responsive diarrhea (FRD) are common chronic enteropathies in dogs, of which the exact pathogenesis has not been fully understood. In people dyslipidemia has been reported in patients with IBD, and potential therapeutic benefits of polyunsaturated fatty acids (PUFA) in the treatment of IBD have been investigated. Studies on the phospholipid profile in dogs with IBD and FRD are still lacking.<h4>Aim</h4>To investigate the systemic phosp  ...[more]

Similar Datasets

| S-EPMC3530590 | biostudies-literature
| S-EPMC6335819 | biostudies-literature
| S-EPMC10105444 | biostudies-literature
| S-EPMC4615558 | biostudies-literature
2019-09-03 | ST001247 | MetabolomicsWorkbench
| S-EPMC5465427 | biostudies-literature
| S-EPMC9233311 | biostudies-literature
| S-EPMC3376104 | biostudies-literature
| S-EPMC3086253 | biostudies-literature
| S-EPMC3403081 | biostudies-literature